Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cadaver-donor renal retransplants

Y W Cho, J M Cecka

    Clinical Transplants
    |January 1, 1993
    PubMed
    Summary
    This summary is machine-generated.

    Second kidney transplants show improved survival rates, nearing those of first transplants. Longer time between transplants and specific HLA matching significantly boost success, while donor age and sensitization impact outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical characteristics and outcomes of Clostridioides difficile infection in the intensive care unit: a KASID multi-centre study.

    The Journal of hospital infection·2023
    Same author

    Potential anti-ageing effect of chondroitin sulphate through skin regeneration.

    International journal of cosmetic science·2020
    Same author

    Paul I. Terasaki, PhD, 1929-2016.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    HLA high-resolution typing for sensitized patients: a solution in search of a problem?

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    Kidney paired donation in the presence of donor-specific antibodies.

    Kidney international·2013
    Same author

    Is severe pain immediately after spinal augmentation a predictor of long-term outcomes?

    AJNR. American journal of neuroradiology·2013

    Area of Science:

    • Nephrology
    • Transplantation immunology
    • Organ transplantation

    Background:

    • Kidney retransplantation outcomes have historically lagged behind primary transplants.
    • Factors influencing second graft survival require ongoing investigation to optimize patient care.
    • Improvements in immunosuppression and donor selection strategies are crucial for retransplant success.

    Purpose of the Study:

    • To analyze trends and identify key predictors of survival in kidney retransplantation.
    • To evaluate the impact of pre-transplant sensitization, HLA matching, and donor characteristics on regraft survival.
    • To assess the efficacy of antibody induction therapy in improving outcomes for second and multiple kidney transplants.

    Main Methods:

    • Retrospective analysis of kidney retransplant patient data.

    Related Experiment Videos

  • Statistical evaluation of survival rates based on patient and donor factors, including pre-transplant sensitization (PRA), HLA antigen matching, and donor age.
  • Comparison of outcomes with and without prophylactic OKT3 antibody induction.

    • Main Results:

    • One-year regraft survival rates for second transplants improved significantly, approaching primary transplant survival rates.
    • Longer post-explant survival time (PGST) and specific HLA-DR antigen matching were strong positive predictors of regraft success.
    • High levels of panel reactive antibodies (PRA > 50%), repeated HLA-DR mismatches, and extreme donor ages (<6 or >55 years) were associated with poorer outcomes. Prophylactic OKT3 improved survival.

    Conclusions:

    • Kidney retransplantation survival rates have dramatically improved, making them a viable option for select patients.
    • Careful patient selection, including assessment of PGST and sensitization, along with optimized HLA matching and donor selection, is critical.
    • The use of cadaver-donor kidneys for retransplantation is justified in low-risk patients, supported by improved survival statistics and effective immunosuppression protocols.